Bioniq Secures £851,000 to Enhance Personalised Health Solutions
In a remarkable convergence of sports, technology, and health, Bioniq has attracted attention with a bold £851,000 funding round led by Manchester United’s Diogo Dalot. This significant investment underscores the increasing interest in personalized health solutions, especially those that leverage data science for enhanced wellness. With the backing of high-profile figures like Dalot and global icon Cristiano Ronaldo, who joined as a major investor in 2024, Bioniq is not just charting a new course in nutritional supplements but is also solidifying its position in a rapidly evolving market.
Bioniq, based in London, UK, is pioneering the use of blood biomarker data to create individualized nutritional supplements.
Under the leadership of CEO and Founder Vadim Fedotov, the company has built a notable reputation by combining artificial intelligence and personalized health strategies. With funding now totaling over €1M, Bioniq aims to expand its operations and strengthen its business reach, enhancing its capability to serve an increasingly health-conscious global market. This move follows a successful Series B funding round that raised $15M, supported by top-tier European VCs like HV Capital and Unbound, showcasing robust investor confidence in Bioniq’s growth potential.
At the heart of Bioniq’s innovation lies a proprietary biochemical database that harnesses blood test data from over 300,000 users across five continents. This extensive data enables the company to formulate personalized supplements tailored to individuals’ specific nutrient deficiencies, as indicated by their blood results. As Bioniq prepares to navigate the next stages of its journey, it represents an inspiring case study for startup founders and investors alike, illustrating how targeted funding and innovative technology can transform the health and wellness industry. In an era where personalization is king, Bioniq stands poised to redefine nutritional supplementation and meet the demands of a diverse and global customer base.
Key Terms Explained
- Funding Round
- A funding round refers to the process of raising capital through the sale of shares to private investors, venture capitalists, or crowdfunding platforms.
- Blood Biomarker Data
- Blood biomarker data refers to the measurable indicators of a biological condition or state gleaned from blood tests. This data can indicate normal biological processes, pathogenic processes, or responses to an exposure or intervention.
- Personalized Health Solutions
- Personalized health solutions refer to medical practices, interventions, or products tailored to the individual patient based on their predicted response or risk of disease. These solutions often leverage data science and technology for a more optimized health outcome.
Frequently Asked Questions
- Who led the £851,000 funding round for Bioniq?-Manchester United’s Diogo Dalot led the £851,000 funding round for Bioniq.
- What is Bioniq's approach to personalized health solutions?+
- What is the total amount of funding Bioniq received?+
- Who are the major investors in Bioniq?+
- What is the plan for Bioniq with the new funding?+
They've invested in Bioniq
Get to know these Healthtech investors
Click here for a full list of 7,526+ startup investors in the UK